January 06, 2025

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

Patients with early-onset breast cancer (aged 40 or younger at diagnosis) who have BRCA1 and/or BRCA2 pathogenic or likely pathogenic variants had improved overall survival by undergoing risk-reducing...

The ASCO Post

December 23, 2024

Combination of Two Oral Agents May Improve Progression-Free Survival in Patients With Previously Untreated CLL

The ASCO Post

January 06, 2025

RELATIVITY-047: Extended Analysis of Overall Survival With Nivolumab/Relatlimab vs Nivolumab in Previously Untreated Advanced Melanoma

The ASCO Post

December 16, 2024

Negative Colonoscopy Screening Results and Risk for Colorectal Cancer and Mortality

The ASCO Post

January 06, 2025

Advanced Imaging May Uncover Hidden Metastases in High-Risk Prostate Cancer Cases

The ASCO Post

December 04, 2024

Lenvatinib/Pembrolizumab vs Chemotherapy in Advanced Endometrial Cancer

The ASCO Post

Latest Headlines

February 03, 2025

Chemotherapy Linked to Chronic Neuropathy for 4 in Every 10 Patients: Global Analysis Results

The ASCO Post

February 03, 2025

Cancer Symptoms Mistaken for Pregnancy Symptoms Could Lead to Delays in Cancer Diagnosis

The ASCO Post

February 03, 2025

Salpingectomy During Other Abdominal Surgeries May Lower Ovarian Cancer Risk

The ASCO Post

February 03, 2025

Addition of Bevacizumab to Pembrolizumab in Platinum-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma

The ASCO Post

February 03, 2025

Thermal Ablation vs Surgical Resection of Small Resectable Colorectal Liver Metastases

The ASCO Post

February 03, 2025

Novel BTK and BCL2 Inhibitors Redefine CLL Treatment Across Front-Line and Relapsed Settings

The ASCO Post

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

Conference Coverage

All Conference News View Conference Calendar

2024 ASH Annual Meeting

February 03, 2025

Novel BTK and BCL2 Inhibitors Redefine CLL Treatment Across Front-Line and Relapsed Settings

The ASCO Post

January 30, 2025

BOREAS Trial: Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis

The ASCO Post

January 23, 2025

AALL1731 Trial: Adding Blinatumomab to Standard Chemotherapy Improves Outcomes in Pediatric B-Cell ALL

The ASCO Post

2025 STS Annual Meeting

January 28, 2025

Anatomic Lung Resection May Be Linked to Improved Survival in Early-Stage NSCLC

The ASCO Post

2025 ASCO GI

January 27, 2025

New Research Explores Blood Test to Determine Prognosis, Benefit of Celecoxib in Stage III Colon Cancer

The ASCO Post

January 27, 2025

New Findings on Aspirin and Risk of Colorectal Cancer Recurrence

The ASCO Post

January 27, 2025

Novel Combination Targeted Therapies, Chemotherapy in BRAF-Mutated Metastatic Colorectal Cancer

The ASCO Post

Clinical Guidelines

January 29, 2025

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma

The ASCO Post

January 28, 2025

T-DXd Approved by the FDA for Pretreated Patients With HER2-Low or -Ultralow Metastatic Breast Cancer

The ASCO Post

January 07, 2025

Addition of Palbociclib to Standard Therapy in Metastatic Hormone Receptor–Positive, HER2-Positive Breast Cancer

The ASCO Post

January 06, 2025

Risk-Reducing Surgeries Improve Survival for Younger Patients With Breast Cancer Who Are BRCA Carriers, Study Finds

The ASCO Post

Commentary & Perspectives

July 10, 2023

Expert Point of View: Pamela L. Kunz, MD and Corrie Marijnen, MD, PhD

The ASCO Post

January 25, 2023

Communicating Prognosis: A Core Competency of Patient-Centered Oncology Care

The ASCO Post

June 09, 2023

Rethinking Prior Authorization

The ASCO Post

October 25, 2023

Gender Equity in Academic Hematology: Where There’s a ‘WiL,’ There’s a Way

The ASCO Post

FDA & Government News

January 29, 2025

FDA Highlights Importance of DPD Deficiency Discussions With Patients Prior to Capecitabine or Fluorouracil Treatment

The ASCO Post

January 17, 2025

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

The ASCO Post

January 17, 2025

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

The ASCO Post

July 18, 2023

First Oral Medication to Treat Moderate-to-Severe Crohn’s Disease Earns FDA Approval

Mount Sinai New York

Business Management

April 01, 2023

Change is Constant

Inside Dental Hygiene

February 08, 2023

Machine Learning and the Power to Outsmart Cancer

Cedars-Sinai Pulse

June 10, 2024

How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life

The ASCO Post

March 01, 2023

Exceeding Patient Expectations With Bioceramic Cements and More

Inside Dentistry

Trending Now

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dental Technology

Inside Dentistry

Special Issues

The ASCO Post

JADPRO

JNCCN

JNCCN 360

Corneal Physician

Glaucoma Physician

New Retinal Physician

Ophthalmology Management

Ophthalmic Professional

Presbyopia Physician

Retinal Physician

Contact Lens Spectrum

Eyecare Business

Optometric Management

Presbyopia Physician

Negative Colonoscopy Screening Results and Risk for Colorectal Cancer and Mortality

Advanced Imaging May Uncover Hidden Metastases in High-Risk Prostate Cancer Cases

Lenvatinib/Pembrolizumab vs Chemotherapy in Advanced Endometrial Cancer

Latest Headlines

Daily News

Recommendations

Featured Videos

Conference Coverage

2024 ASH Annual Meeting

2025 STS Annual Meeting

2025 ASCO GI

Clinical Guidelines

Commentary & Perspectives

FDA & Government News

Business Management